• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

PET Tracer Captures Astrocytosis in Alzheimer’s Patients

Article

The positron emission tomography tracer C-deuterium-L-deprenyl (11C-DED) can help physicians visualize astrocytes, which is thought to conspire with amyloid-beta plaques in the progression of Alzheimer disease.

The positron emission tomography tracer C-deuterium-L-deprenyl (11C-DED) can help physicians visualize astrocytes, which is thought to conspire with amyloid-beta plaques in the progression of Alzheimer disease.

That’s the conclusion of a small Swedish study published in the January edition of the Journal of Nuclear Medicine. It follows closely on the heels of a December 2010 European Journal of Nuclear Medicine and Molecular Imaging study that arrived at similar findings.

In the Swedish study, researchers did a multitracer PET investigation for patients with mild cognitive impairment (MCI), patients with mild Alzheimer disease, and healthy controls using 11C-DED to measure monoamine oxidase B located in astrocytes. Along with 11C-DED PET, data on 11C-Pittsburgh compound B (11C-PIB; fibrillar Aβ deposition), 18F-FDG (18F-fluoro-deoxy-glucose to measure glucose metabolism), MRI, cerebrospinal fluid, and neuropsychologic were acquired from the patients.

11C-DED PET was performed for eight MCI patients, seven Alzheimer disease patients, and 14 healthy controls. 11C-DED data from 20 to 60 min were analyzed using a digital brain atlas. Mean regional 18F-FDG uptake and 11C-PIB retention were calculated for each patient, with cerebellar gray matter as a reference.

Analysis of the regional 11C-DED binding data revealed increased binding in the bilateral frontal and bilateral parietal cortices of the MCI patients. Increased 11C-DED binding in most cortical and subcortical regions was observed in MCI 11C-PIB+ patients relative to controls, MCI 11C-PIB (negative) patients, and patients with Alzheimer disease. No regional correlations were found between the three PET tracers.

“Increased 11C-DED binding throughout the brain of the MCI 11C-PIB+ patients potentially suggests that astrocytosis is an early phenomenon in [Alzheimer disease] development,” the researchers wrote.
 

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.